Aptamer Group (LON:APTA) Trading Up 13.6% – Here’s Why

Aptamer Group plc (LON:APTA)’s stock price was up 13.6% on Wednesday . The company traded as high as GBX 1 ($0.01) and last traded at GBX 1 ($0.01). Approximately 15,553,100 shares were traded during mid-day trading, a decline of 14% from the average daily volume of 18,117,180 shares. The stock had previously closed at GBX 0.88 ($0.01).

Aptamer Group Stock Up 8.5%

The stock’s 50 day moving average is GBX 0.88 and its two-hundred day moving average is GBX 0.53. The company has a market capitalization of £25.76 million, a PE ratio of -341.07 and a beta of -0.52.

Aptamer Group (LON:APTA) last announced its earnings results on Tuesday, October 14th. The company reported GBX 0.14 EPS for the quarter. Aptamer Group had a negative net margin of 343.95% and a negative return on equity of 205.63%.

Insider Buying and Selling

In other news, insider Adam Hargreaves bought 5,000,000 shares of Aptamer Group stock in a transaction on Monday, September 8th. The stock was acquired at an average cost of GBX 1 per share, for a total transaction of £50,000. Corporate insiders own 8.76% of the company’s stock.

Aptamer Group Company Profile

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.